These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24004288)

  • 21. LEA3D: a computer-aided ligand design for structure-based drug design.
    Douguet D; Munier-Lehmann H; Labesse G; Pochet S
    J Med Chem; 2005 Apr; 48(7):2457-68. PubMed ID: 15801836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SkelGen: a general tool for structure-based de novo ligand design.
    Dean PM; Firth-Clark S; Harris W; Kirton SB; Todorov NP
    Expert Opin Drug Discov; 2006 Jul; 1(2):179-89. PubMed ID: 23495800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo gene synthesis design using TmPrime software.
    Li MH; Bode M; Huang MC; Cheong WC; Lim LS
    Methods Mol Biol; 2012; 852():225-34. PubMed ID: 22328437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo design: balancing novelty and confined chemical space.
    Kutchukian PS; Shakhnovich EI
    Expert Opin Drug Discov; 2010 Aug; 5(8):789-812. PubMed ID: 22827800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo sequencing methods in proteomics.
    Hughes C; Ma B; Lajoie GA
    Methods Mol Biol; 2010; 604():105-21. PubMed ID: 20013367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LiGen: a high performance workflow for chemistry driven de novo design.
    Beccari AR; Cavazzoni C; Beato C; Costantino G
    J Chem Inf Model; 2013 Jun; 53(6):1518-27. PubMed ID: 23617275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].
    Hirono S
    Rinsho Byori; 2002 Jan; 50(1):45-51. PubMed ID: 11871136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-aided drug design: crystallography and computational approaches.
    Ringe D
    J Nucl Med; 1995 Jun; 36(6 Suppl):28S-30S. PubMed ID: 7769464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NovoFLAP: A ligand-based de novo design approach for the generation of medicinally relevant ideas.
    Damewood JR; Lerman CL; Masek BB
    J Chem Inf Model; 2010 Jul; 50(7):1296-303. PubMed ID: 20586434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Building block synthesis using the polymerase chain assembly method.
    Marchand JA; Peccoud J
    Methods Mol Biol; 2012; 852():3-10. PubMed ID: 22328421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Error-estimation-guided rebuilding of de novo models increases the success rate of ab initio phasing.
    Shrestha R; Simoncini D; Zhang KY
    Acta Crystallogr D Biol Crystallogr; 2012 Nov; 68(Pt 11):1522-34. PubMed ID: 23090401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ab initio prediction of the three-dimensional structure of a de novo designed protein: a double-blind case study.
    Klepeis JL; Wei Y; Hecht MH; Floudas CA
    Proteins; 2005 Feb; 58(3):560-70. PubMed ID: 15609306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.
    Caballero J; Alzate-Morales JH; Vergara-Jaque A
    J Chem Inf Model; 2011 Nov; 51(11):2920-31. PubMed ID: 22011048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo design of the hydrophobic cores of proteins.
    Desjarlais JR; Handel TM
    Protein Sci; 1995 Oct; 4(10):2006-18. PubMed ID: 8535237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AISMIG--an interactive server-side molecule image generator.
    Bohne-Lang A; Groch WD; Ranzinger R
    Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W705-9. PubMed ID: 15980568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hybrid method for peptide identification using integer linear optimization, local database search, and quadrupole time-of-flight or OrbiTrap tandem mass spectrometry.
    DiMaggio PA; Floudas CA; Lu B; Yates JR
    J Proteome Res; 2008 Apr; 7(4):1584-93. PubMed ID: 18324765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.